share_log

Shandong Fengyuan Chemical Co., Ltd.'s (SZSE:002805) 16% Gain Last Week Benefited Both Retail Investors Who Own 56% as Well as Insiders

Simply Wall St ·  Sep 5 20:18

Key Insights

  • Shandong Fengyuan Chemical's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • The top 25 shareholders own 44% of the company
  • Insider ownership in Shandong Fengyuan Chemical is 31%

Every investor in Shandong Fengyuan Chemical Co., Ltd. (SZSE:002805) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the company with 56% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

While retail investors were the group that benefitted the most from last week's CN¥462m market cap gain, insiders too had a 31% share in those profits.

Let's delve deeper into each type of owner of Shandong Fengyuan Chemical, beginning with the chart below.

big
SZSE:002805 Ownership Breakdown September 6th 2024

What Does The Institutional Ownership Tell Us About Shandong Fengyuan Chemical?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Shandong Fengyuan Chemical already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shandong Fengyuan Chemical, (below). Of course, keep in mind that there are other factors to consider, too.

big
SZSE:002805 Earnings and Revenue Growth September 6th 2024

We note that hedge funds don't have a meaningful investment in Shandong Fengyuan Chemical. Looking at our data, we can see that the largest shareholder is Zhao Guanghui with 30% of shares outstanding. With 5.4% and 1.2% of the shares outstanding respectively, Jintong Anyi Investment Management Co., Ltd. and UBS Asset Management AG are the second and third largest shareholders.

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

Insider Ownership Of Shandong Fengyuan Chemical

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Our information suggests that insiders maintain a significant holding in Shandong Fengyuan Chemical Co., Ltd.. Insiders own CN¥1.0b worth of shares in the CN¥3.3b company. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

General Public Ownership

The general public, mostly comprising of individual investors, collectively holds 56% of Shandong Fengyuan Chemical shares. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.

Private Equity Ownership

Private equity firms hold a 5.4% stake in Shandong Fengyuan Chemical. This suggests they can be influential in key policy decisions. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Shandong Fengyuan Chemical better, we need to consider many other factors. Be aware that Shandong Fengyuan Chemical is showing 3 warning signs in our investment analysis , and 2 of those are a bit concerning...

Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment